American Superconductor Corporation (BIT:1AMSC)
Italy · Delayed Price · Currency is EUR 31.64
0.00 (0.00%)
At close: Jul 28, 2025, 5:30 PM CET
Verve Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | 15.28 | 6.03 | -11.11 | -35.04 | -19.19 | -22.68 | Upgrade |
Depreciation & Amortization | 6.81 | 6.54 | 4.82 | 5.36 | 5.34 | 5.35 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | 1.92 | - | - | Upgrade |
Loss (Gain) on Equity Investments | -0.16 | 0.13 | - | - | - | - | Upgrade |
Stock-Based Compensation | 11.09 | 7.79 | 4.65 | 4.73 | 4.66 | 3.49 | Upgrade |
Other Operating Activities | -0.28 | 3.28 | 7 | 1.94 | -6.06 | 4.14 | Upgrade |
Change in Accounts Receivable | -14.51 | -3.21 | 4.34 | -10.36 | -3.76 | 5.19 | Upgrade |
Change in Inventory | -4.95 | -7.71 | -6.84 | -14.8 | -3.31 | 8.11 | Upgrade |
Change in Accounts Payable | 11.26 | 3.21 | -13.5 | 8.66 | 4.7 | -5.05 | Upgrade |
Change in Unearned Revenue | 7.34 | 13.24 | 7.12 | 20.86 | -0.93 | -8.06 | Upgrade |
Change in Other Net Operating Assets | -2.87 | -1.02 | 5.67 | -5.76 | -0.42 | 0.82 | Upgrade |
Operating Cash Flow | 29 | 28.29 | 2.14 | -22.49 | -18.98 | -8.68 | Upgrade |
Operating Cash Flow Growth | 272.19% | 1222.96% | - | - | - | - | Upgrade |
Capital Expenditures | -2.96 | -2.42 | -0.93 | -1.24 | -0.94 | -1.76 | Upgrade |
Cash Acquisitions | -29.58 | -29.58 | - | - | -11.48 | -26 | Upgrade |
Investment in Securities | - | - | - | - | 5.19 | 30.15 | Upgrade |
Other Investing Activities | -3.38 | -3.21 | -0.03 | -0.28 | 0.07 | 0.08 | Upgrade |
Investing Cash Flow | -35.92 | -35.21 | -0.96 | -1.52 | -7.16 | 2.47 | Upgrade |
Long-Term Debt Repaid | - | -0.03 | -0.07 | -0.07 | -0.05 | - | Upgrade |
Net Debt Issued (Repaid) | -0.01 | -0.03 | -0.07 | -0.07 | -0.05 | - | Upgrade |
Issuance of Common Stock | 124.88 | 0.31 | 65.51 | 0.24 | 0.24 | 51.76 | Upgrade |
Repurchase of Common Stock | - | -0.13 | - | - | -0.05 | -0.93 | Upgrade |
Other Financing Activities | -0.15 | -0.15 | - | - | - | - | Upgrade |
Financing Cash Flow | 124.73 | 0.01 | 65.44 | 0.16 | 0.14 | 50.83 | Upgrade |
Foreign Exchange Rate Adjustments | 0.09 | 0.01 | -0.01 | 0.03 | -0.06 | 0.06 | Upgrade |
Net Cash Flow | 117.9 | -6.9 | 66.61 | -23.81 | -26.05 | 44.68 | Upgrade |
Free Cash Flow | 26.04 | 25.87 | 1.2 | -23.72 | -19.92 | -10.45 | Upgrade |
Free Cash Flow Growth | 282.50% | 2048.67% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 10.21% | 11.61% | 0.83% | -22.38% | -18.37% | -11.99% | Upgrade |
Free Cash Flow Per Share | 0.67 | 0.69 | 0.04 | -0.85 | -0.73 | -0.44 | Upgrade |
Cash Income Tax Paid | 0.2 | 0.31 | 0.29 | 0.35 | 0.53 | 0.59 | Upgrade |
Levered Free Cash Flow | -18.36 | -12.33 | 6.81 | -9.47 | -15.35 | 2.49 | Upgrade |
Unlevered Free Cash Flow | -18.36 | -12.33 | 6.81 | -9.47 | -15.35 | 2.49 | Upgrade |
Change in Net Working Capital | 42.25 | 30.07 | -1.71 | -1.01 | 8.45 | -6.76 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.